Using Telemedicine to Improve Spasticity Diagnosis Rates

Sponsor
Vanderbilt University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT03211390
Collaborator
Allergan (Industry)
60
1
6
10

Study Details

Study Description

Brief Summary

The purpose of this study is to test the reliability of using telemedicine so a neurologist can remotely identify residents of a long-term care facility who should be referred to a neurologist for an in-person spasticity consultation.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Neurological Examination
  • Diagnostic Test: Teleneurological Examination

Detailed Description

The aim of this study is to improve spasticity (a form of muscle rigidity) diagnosis through validation of telemedicine as a tool for spasticity evaluation or referral. This study will test the reliability of using telemedicine so a neurologist can remotely identify residents of a long-term care facility who should be referred to a neurologist for an in-person spasticity consultation. The telemedicine referral tool will be tested for bedside implementation in all consenting participants residing in Tennessee State Veteran's Home, which is a long-term care facility in Murfreesboro, TN. Each of the 140 residents will receive one neurological examination and one physical examination guided by the teleneurologist. A medical record review will also be performed.

Study Design

Study Type:
Observational
Actual Enrollment :
60 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Using Telemedicine to Improve Spasticity Diagnosis Rates
Actual Study Start Date :
Jan 30, 2018
Actual Primary Completion Date :
Aug 1, 2018
Actual Study Completion Date :
Aug 1, 2018

Outcome Measures

Primary Outcome Measures

  1. Sensitivity of Teleneurology [Up to three months after consent is obtained]

    A Vanderbilt neurologist will examine all consented residents for spasticity using a telemedicine platform, with the assistance of a nurse at the subject's bedside. The findings of the exam will be recorded by the research coordinator. Agreement on spasticity referral between the Vanderbilt neurologist who performed the teleneurological examination and the neurologist who performed the "gold standard" examination will be determined.

Secondary Outcome Measures

  1. Specificity of Teleneurology [Up to three months after consent is obtained]

    A Vanderbilt neurologist will examine all consented residents for spasticity using a telemedicine platform, with the assistance of a nurse at the subject's bedside. The findings of the exam will be recorded by the research coordinator. Agreement on spasticity referral between the Vanderbilt neurologist who performed the teleneurological examination and the neurologist who performed the "gold standard" examination will be determined.

  2. Spasticity Diagnosis [Up to three months after consent is obtained]

    There is no biomarker for spasticity. Therefore, the diagnosis will be made on physician impression. A neurologist trained in movement disorders will examine each consented patient to determine if they have spasticity. The severity of the subject's spasticity will be documented, including the following measures: presence of fixed contractures and presence of pain on movement.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male or female subjects of any race, aged 18 and above

  • Resident of the selected long-term care facility

  • The subject, or if appropriate their medical decision maker, is willing and able to provide written informed consent.

Exclusion Criteria:
  • Subjects for whom participation in the study may cause medical harm

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tennessee State Veterans' Homes Murfreesboro Tennessee United States 37130

Sponsors and Collaborators

  • Vanderbilt University Medical Center
  • Allergan

Investigators

  • Principal Investigator: David Charles, M.D., Vanderbilt University Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
David Charles, Professor and Vice-Chairman of Neurology, Vanderbilt University Medical Center
ClinicalTrials.gov Identifier:
NCT03211390
Other Study ID Numbers:
  • 170703
First Posted:
Jul 7, 2017
Last Update Posted:
Oct 9, 2018
Last Verified:
Oct 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 9, 2018